Why TFF Pharmaceuticals Is Trading Higher Today

TFF Pharmaceuticals TFFP shares are trading higher after the company on Thursday reported a global licensing deal with UNION therapeutics for its Thin Film Freezing technology in combination with niclosamide.

As part of the agreement, UNION agreed to pay TFF Pharmaceuticals potential development, regulatory and sales-related milestone payments of up to $210 million. UNION will also pay TFF tiered single-digit royalties on product sales. 

TFF Pharmaceuticals is focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. 

TFF Pharmaceuticals was trading 22.32% higher at $12.57 at time of publication. The stock has a 52-week high of $13.18 and a 52-week low of $3.44.